Rapid Diagnostic

Hepatitis B Surface Antigen (HBsAg)/Hepatitis C Virus Antibody (HCV Ab) Combo Rapid Test

Simultaneous detection of HBsAg and HCV Ab for efficient screening.

CE Certified
ISO 13485
Main image of Hepatitis B Surface Antigen (HBsAg)/Hepatitis C Virus Antibody (HCV Ab) Combo Rapid Test

Why Choose reOpenTest Infectious Disease Kits?

Our tests are engineered for accuracy, reliability, and ease of use, ensuring confidence in every result.

Dual Analyte Detection

Simultaneously detects HBsAg and HCV Ab, saving time and resources.

Rapid Results

Provides results in 15-20 minutes, enabling quick clinical decisions.

Multiple Sample Types

Suitable for whole blood, serum, or plasma samples.

Product Overview

The Hepatitis B Surface Antigen (HBsAg)/Hepatitis C Virus Antibody (HCV Ab) Combo Rapid Test is a qualitative in vitro diagnostic device designed for the simultaneous detection of Hepatitis B surface antigen (HBsAg) and antibodies to Hepatitis C virus (HCV Ab) in human whole blood, serum, or plasma. This rapid test provides a convenient and efficient method for screening individuals for these viral infections.

Technical Specifications

Detection Target Hepatitis B Surface Antigen (HBsAg), Hepatitis C Virus Antibody (HCV Ab)
Sample Type Whole blood, Serum, Plasma
Methodology Immunochromatography
Detection Range Qualitative: Positive/Negative
Reaction Time 15-20 minutes
Storage Conditions 2-30u00b0C
Shelf Life 24 months

Procedure & Interpretation

Step-by-Step Procedure

  1. Add the sample to the test cassette.
  2. Wait for 15-20 minutes.
  3. Read and interpret the results.

Result Interpretation

Positive Result
Positive: Visible bands for both HBsAg and/or HCV Ab indicate a positive result.
Negative Result
Negative: Only the control band is visible, indicating a negative result.
Invalid Result
Invalid: No control band appears, indicating an invalid test. Repeat the test with a new cassette.

Frequently Asked Questions

Simultaneous detection allows for rapid screening and identification of individuals infected with either Hepatitis B or Hepatitis C, enabling timely treatment and preventing further transmission.

No, this test is a screening tool and cannot differentiate between acute and chronic infections. Further confirmatory tests are required.

The test should be stored at 2-30u00b0C to maintain its stability and performance.

Technical Documents

Download product inserts and brochures for detailed information.

No technical documents are available at this time. Please check back soon.

Partner with reOpenTest

Provide your clients and patients with reliable diagnostic solutions.
Contact us today for bulk pricing and distribution opportunities.

Become a Distributor